Quadrant Capital Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-66
| Closed | -$785 | – | 2159 |
|
|
2025
Q1 | $785 | Hold |
66
| – | – | ﹤0.01% | 2608 |
|
|
2024
Q4 | $1.24K | Hold |
66
| – | – | ﹤0.01% | 2562 |
|
|
2024
Q3 | $1.48K | Hold |
66
| – | – | ﹤0.01% | 2538 |
|
|
2024
Q2 | $1.38K | Hold |
66
| – | – | ﹤0.01% | 2527 |
|
|
2024
Q1 | $971 | Hold |
66
| – | – | ﹤0.01% | 2590 |
|
|
2023
Q4 | $682 | Sell |
66
-49
| -43% | -$506 | ﹤0.01% | 2591 |
|
|
2023
Q3 | $904 | Sell |
115
-1,367
| -92% | -$10.7K | ﹤0.01% | 2498 |
|
|
2023
Q2 | $14.8K | Hold |
1,482
| – | – | ﹤0.01% | 1859 |
|
|
2023
Q1 | $13.2K | Buy |
+1,482
| New | +$13.2K | ﹤0.01% | 1903 |
|